Linked Life Data

2598776

Source:http://linkedlifedata.com/resource/pubmed/id/2598776

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1990-2-7
pubmed:abstractText
A total of 1724 clinical isolates from patients with different infections were tested in vitro to determine their susceptibility to norfloxacin. Antibacterial activity of norfloxacin was compared with other drugs that were commonly used in the hospital. Of the 919 strains of Enterobacteriaceae tested, all except four isolates of Enterobacter, two of Serratia and one of Proteus were susceptible to norfloxacin. Ninety-five percent of the 199 strains of Pseudomonas aeruginosa were also inhibited by this quinolone. Brucella melitensis (81 strains) was completely susceptible to norfloxacin. All the 250 isolates of Staphylococcus aureus and coagulase-negative staphylococci were also sensitive to norfloxacin. Pseudomonads other than P.aeruginosa, Acinetobacter/Alcaligenes and group D streptococci were less sensitive to norfloxacin, with 56%, 57% and 20% respectively being inhibited by this antimicrobial agent.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0378-6501
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
349-53
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
pubmed:affiliation
King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
pubmed:publicationType
Journal Article